Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions

Abstract excerpt

PURPOSE OF REVIEW: Calcific aortic valve disease (CAVD), the most common cause of aortic stenosis (AS), is characterized by slowly progressive fibrocalcific remodelling of the valve cusps. Once symptomatic, severe AS is associated with poor survival unless surgical or transcatheter valve replacement is performed. Unfortunately, no pharmacological interventions have been demonstrated to alter the natural history...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac Valve Diseases and Treatments
• Share to Cardiomyopathy and Myosin Studies
• Share to Lipoproteins and Cardiovascular Health